J.F. Chatal
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Oncology top 10%
- HER2/EGFR in Cancer Research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 26
- Monoclonal and Polyclonal Antibodies Research 18
- Medical Imaging Techniques and Applications 7
- Oncology 12
- Colorectal Cancer Treatments and Studies 4
- Peptidase Inhibition and Analysis 4
- Co-authors
- Manuel Bardiès (5 shared papers)Jean‐Yves Douillard (5 shared papers)C. Curtet (9 shared papers)J.C. Saccavini (8 shared papers)Jacques Barbet (8 shared papers)M. Krémer (5 shared papers)Hilary Koprowski (3 shared papers)P. Fumoleau (3 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (6 papers)Nuclear Medicine and Biology (4 papers)Bioconjugate Chemistry (2 papers)Journal of Clinical Oncology (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
J.F. Chatal
49 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 92
- Radiology, Nuclear Medicine and Imaging 957
- Oncology 329
- Radiation 104
- Endocrinology, Diabetes and Metabolism 103
- Pulmonary and Respiratory Medicine 193
Countries citing papers authored by J.F. Chatal
This map shows the geographic impact of J.F. Chatal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.F. Chatal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.F. Chatal more than expected).
Fields of papers citing papers by J.F. Chatal
This network shows the impact of papers produced by J.F. Chatal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.F. Chatal. The network helps show where J.F. Chatal may publish in the future.
Co-authors
The 25 scholars most cited alongside J.F. Chatal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. | 1983 | 221 |
| 2 | 1997 | 179 | |
| 3 | Immunoscintigraphy of colon carcinoma. | 1984 | 149 |
| 4 | 1994 | 74 | |
| 5 | 2006 | 72 | |
| 6 | Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. | 1993 | 69 |
| 7 | Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. | 1993 | 68 |
| 8 | 2005 | 50 | |
| 9 | A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma. | 1999 | 46 |
| 10 | Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial. | 1999 | 42 |
| 11 | 1986 | 36 | |
| 12 | 2000 | 35 | |
| 13 | Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma. | 1989 | 30 |
| 14 | 1990 | 28 | |
| 15 | 1992 | 25 | |
| 16 | Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections. | 1999 | 25 |
| 17 | Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma. | 1999 | 25 |
| 18 | 2001 | 20 | |
| 19 | 1999 | 20 | |
| 20 | 1993 | 13 |
About J.F. Chatal
J.F. Chatal is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (26 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Medical Imaging Techniques and Applications (7 papers), Ovarian cancer diagnosis and treatment (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Peptidase Inhibition and Analysis (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (957 citations), Oncology (329 citations), Radiation (104 citations), Endocrinology, Diabetes and Metabolism (103 citations) and Pulmonary and Respiratory Medicine (193 citations). J.F. Chatal has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Manuel Bardiès, Jean‐Yves Douillard, C. Curtet, J.C. Saccavini, Jacques Barbet, M. Krémer, Hilary Koprowski, P. Fumoleau, I. Resche and J.-P. Mach. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Nuclear Medicine and Biology, Bioconjugate Chemistry, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.